Bausch + Lomb (BLCO) Q4 2025 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
Bausch + Lomb Corporation Common Shares (BLCO)
Company Research
Source: Globe and Mail, The
Chief Financial Officer — Osama Eldessouky President, Global Pharmaceuticals and International Consumer — Andrew Stewart Executive Vice President, Research and Development — Yehia Hashad Takeaways Total Revenue -- $1.405 billion, up 7% constant currency; highest quarterly revenue in company history. Adjusted EBITDA -- $330 million, up 27% year over year; margin reached 23.5%, a record since IPO. Full year revenue -- $5.101 billion, up 5% (6% excluding enVista recall). Operating leverage -- Adjusted EBITDA increased nearly 3x the rate of revenue growth in the quarter. Vision Care segment -- $778 million in quarterly revenue (up 5%); full year $2.923 billion (up 6%). Contact lenses -- Quarterly revenue up 8%; U.S. up 11%, international up 6%; China up 7% in the quarter and 8% for the year. DD SiHy contact lenses -- Up 17% quarterly and 28% for the year; Ultra up 16% in Q4 and 9% for fiscal 2025. Consumer dry eye portfolio -- Q4 revenue $116 million, up 6%; Blink u
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation Common Shares news events
Weekly update
A roundup of the hottest topics
BLCO
News
- Why Bausch + Lomb (BLCO) Just Strengthened Something Beyond Earnings [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb (BLCO) Q3 2025 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Bausch + Lomb (BLCO) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=BLCO&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" to "MarketBeat
- Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling ProgramBusiness Wire
- Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update [Yahoo! Finance]Yahoo! Finance
BLCO
Earnings
- 2/18/26 - Miss
BLCO
Sec Filings
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- BLCO's page on the SEC website